I am so excited to welcome Amy to our Board of Directors! Her unique experience in combining technology and data science with drug development and regulatory policy will be invaluable to us as we move to the next phase of our journey at insitro. https://t.co/AWKNx6txRa

— Daphne Koller (@DaphneKoller) 3 avril 2024

I am so excited to welcome Amy to our Board of Directors! Her unique experience in combining technology and data science with drug development and regulatory policy will be invaluable to us as we move to the next phase of our journey at insitro. insitro (@insitro) We're thrilled to welcome Dr. Amy Abernethy to our BOD! A clinical research pioneer & hematologist-oncologist, her dedication to data-driven healthcare innovation and transformative drug development on behalf of patients align perfectly with our mission. businesswire.com/news/home/2… — https://nitter.net/insitro/status/1775502758696628425#m

→ View original post on X — @daphnekoller, 2024-04-03 13:38 UTC